Role of carnitine esters in brain neuropathology

l-Carnitine (L-C) is a naturally occurring quaternary ammonium compound endogenous in all mammalian species and is a vital cofactor for the mitochondrial oxidation of fatty acids. Fatty acids are utilized as an energy substrate in all tissues, and although glucose is the main energetic substrate in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular Aspects of Medicine 2004-10, Vol.25 (5), p.533-549
Hauptverfasser: Virmani, Ashraf, Binienda, Zbigniew
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 549
container_issue 5
container_start_page 533
container_title Molecular Aspects of Medicine
container_volume 25
creator Virmani, Ashraf
Binienda, Zbigniew
description l-Carnitine (L-C) is a naturally occurring quaternary ammonium compound endogenous in all mammalian species and is a vital cofactor for the mitochondrial oxidation of fatty acids. Fatty acids are utilized as an energy substrate in all tissues, and although glucose is the main energetic substrate in adult brain, fatty acids have also been shown to be utilized by brain as an energy substrate. L-C also participates in the control of the mitochondrial acyl-CoA/CoA ratio, peroxisomal oxidation of fatty acids, and the production of ketone bodies. Due to their intrinsic interaction with the bioenergetic processes, they play an important role in diseases associated with metabolic compromise, especially mitochondrial-related disorders. A deficiency of carnitine is known to have major deleterious effects on the CNS. Several syndromes of secondary carnitine deficiency have been described that may result from defects in intermediary metabolism and alterations principally involving mitochondrial oxidative pathways. Mitochondrial superoxide formation resulting from disturbed electron transfer within the respiratory chain may affect the activities of respiratory chain complexes I, II, III, IV, and V and underlie some CNS pathologies. This mitochondrial dysfunction may be ameliorated by L-C and its esters. In addition to its metabolic role, L-C and its esters such as acetyl- l-carnitine (ALC) posses unique neuroprotective, neuromodulatory, and neurotrophic properties which may play an important role in counteracting various disease processes. Neural dysfunction and metabolic imbalances underlie many diseases, and the inclusion of metabolic modifiers may provide an alternative and early intervention approach, which may limit further developmental damage, cognitive loss, and improve long-term therapeutic outcomes. The neurophysiological and neuroprotective actions of L-C and ALC on cellular processes in the central and peripheral nervous system show such effects. Indeed, many studies have shown improvement in processes, such as memory and learning, and are discussed in this review.
doi_str_mv 10.1016/j.mam.2004.06.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66872111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0098299704000482</els_id><sourcerecordid>66872111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c330t-eef523f2ea1771e94997213d13bf7875b63430190ba942fc9198cc858345b3db3</originalsourceid><addsrcrecordid>eNp9kE9LxDAQxYMo7rr6AbxIT95aZ5o2bfAk4j9YEETPIU2nmqVt1qQr7Lc3yy548zJzee_x3o-xS4QMAcXNKhv0kOUARQYiA-BHbI51laeyKPNjNgeQdZpLWc3YWQgrACwrUZ6yGZZccFHAnMGb6ylxXWK0H-1kR0ooTORDYsek8TrekTberfX05Xr3uT1nJ53uA10c_oJ9PD683z-ny9enl_u7ZWo4hykl6sqcdzlprCokWcQWOfIWedNVdVU2ghccUEKjZZF3RqKsjanLmhdlw9uGL9j1Pnft3fcmdlKDDYb6Xo_kNkEJEYciYhTiXmi8C8FTp9beDtpvFYLaYVIrFTGpHSYFQkVM0XN1CN80A7V_jgOXKLjdCyhO_LHkVTCWRkOt9WQm1Tr7T_wv_Jp2gA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66872111</pqid></control><display><type>article</type><title>Role of carnitine esters in brain neuropathology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Virmani, Ashraf ; Binienda, Zbigniew</creator><creatorcontrib>Virmani, Ashraf ; Binienda, Zbigniew</creatorcontrib><description>l-Carnitine (L-C) is a naturally occurring quaternary ammonium compound endogenous in all mammalian species and is a vital cofactor for the mitochondrial oxidation of fatty acids. Fatty acids are utilized as an energy substrate in all tissues, and although glucose is the main energetic substrate in adult brain, fatty acids have also been shown to be utilized by brain as an energy substrate. L-C also participates in the control of the mitochondrial acyl-CoA/CoA ratio, peroxisomal oxidation of fatty acids, and the production of ketone bodies. Due to their intrinsic interaction with the bioenergetic processes, they play an important role in diseases associated with metabolic compromise, especially mitochondrial-related disorders. A deficiency of carnitine is known to have major deleterious effects on the CNS. Several syndromes of secondary carnitine deficiency have been described that may result from defects in intermediary metabolism and alterations principally involving mitochondrial oxidative pathways. Mitochondrial superoxide formation resulting from disturbed electron transfer within the respiratory chain may affect the activities of respiratory chain complexes I, II, III, IV, and V and underlie some CNS pathologies. This mitochondrial dysfunction may be ameliorated by L-C and its esters. In addition to its metabolic role, L-C and its esters such as acetyl- l-carnitine (ALC) posses unique neuroprotective, neuromodulatory, and neurotrophic properties which may play an important role in counteracting various disease processes. Neural dysfunction and metabolic imbalances underlie many diseases, and the inclusion of metabolic modifiers may provide an alternative and early intervention approach, which may limit further developmental damage, cognitive loss, and improve long-term therapeutic outcomes. The neurophysiological and neuroprotective actions of L-C and ALC on cellular processes in the central and peripheral nervous system show such effects. Indeed, many studies have shown improvement in processes, such as memory and learning, and are discussed in this review.</description><identifier>ISSN: 0098-2997</identifier><identifier>EISSN: 1872-9452</identifier><identifier>DOI: 10.1016/j.mam.2004.06.003</identifier><identifier>PMID: 15363640</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acetyl- l-carnitine ; Brain ; Brain - metabolism ; Brain - pathology ; Carnitine - chemistry ; Carnitine - deficiency ; Carnitine - metabolism ; Carnitine - therapeutic use ; Cell ; Cell Membrane - metabolism ; Cell Membrane - pathology ; Clinical Trials as Topic ; Esters - metabolism ; FFA ; Humans ; l-Carnitine ; Mitochondria ; Neurons - metabolism ; Neurons - pathology</subject><ispartof>Molecular Aspects of Medicine, 2004-10, Vol.25 (5), p.533-549</ispartof><rights>2004 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c330t-eef523f2ea1771e94997213d13bf7875b63430190ba942fc9198cc858345b3db3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.mam.2004.06.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>313,314,777,781,789,3537,27903,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15363640$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Virmani, Ashraf</creatorcontrib><creatorcontrib>Binienda, Zbigniew</creatorcontrib><title>Role of carnitine esters in brain neuropathology</title><title>Molecular Aspects of Medicine</title><addtitle>Mol Aspects Med</addtitle><description>l-Carnitine (L-C) is a naturally occurring quaternary ammonium compound endogenous in all mammalian species and is a vital cofactor for the mitochondrial oxidation of fatty acids. Fatty acids are utilized as an energy substrate in all tissues, and although glucose is the main energetic substrate in adult brain, fatty acids have also been shown to be utilized by brain as an energy substrate. L-C also participates in the control of the mitochondrial acyl-CoA/CoA ratio, peroxisomal oxidation of fatty acids, and the production of ketone bodies. Due to their intrinsic interaction with the bioenergetic processes, they play an important role in diseases associated with metabolic compromise, especially mitochondrial-related disorders. A deficiency of carnitine is known to have major deleterious effects on the CNS. Several syndromes of secondary carnitine deficiency have been described that may result from defects in intermediary metabolism and alterations principally involving mitochondrial oxidative pathways. Mitochondrial superoxide formation resulting from disturbed electron transfer within the respiratory chain may affect the activities of respiratory chain complexes I, II, III, IV, and V and underlie some CNS pathologies. This mitochondrial dysfunction may be ameliorated by L-C and its esters. In addition to its metabolic role, L-C and its esters such as acetyl- l-carnitine (ALC) posses unique neuroprotective, neuromodulatory, and neurotrophic properties which may play an important role in counteracting various disease processes. Neural dysfunction and metabolic imbalances underlie many diseases, and the inclusion of metabolic modifiers may provide an alternative and early intervention approach, which may limit further developmental damage, cognitive loss, and improve long-term therapeutic outcomes. The neurophysiological and neuroprotective actions of L-C and ALC on cellular processes in the central and peripheral nervous system show such effects. Indeed, many studies have shown improvement in processes, such as memory and learning, and are discussed in this review.</description><subject>Acetyl- l-carnitine</subject><subject>Brain</subject><subject>Brain - metabolism</subject><subject>Brain - pathology</subject><subject>Carnitine - chemistry</subject><subject>Carnitine - deficiency</subject><subject>Carnitine - metabolism</subject><subject>Carnitine - therapeutic use</subject><subject>Cell</subject><subject>Cell Membrane - metabolism</subject><subject>Cell Membrane - pathology</subject><subject>Clinical Trials as Topic</subject><subject>Esters - metabolism</subject><subject>FFA</subject><subject>Humans</subject><subject>l-Carnitine</subject><subject>Mitochondria</subject><subject>Neurons - metabolism</subject><subject>Neurons - pathology</subject><issn>0098-2997</issn><issn>1872-9452</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9LxDAQxYMo7rr6AbxIT95aZ5o2bfAk4j9YEETPIU2nmqVt1qQr7Lc3yy548zJzee_x3o-xS4QMAcXNKhv0kOUARQYiA-BHbI51laeyKPNjNgeQdZpLWc3YWQgrACwrUZ6yGZZccFHAnMGb6ylxXWK0H-1kR0ooTORDYsek8TrekTberfX05Xr3uT1nJ53uA10c_oJ9PD683z-ny9enl_u7ZWo4hykl6sqcdzlprCokWcQWOfIWedNVdVU2ghccUEKjZZF3RqKsjanLmhdlw9uGL9j1Pnft3fcmdlKDDYb6Xo_kNkEJEYciYhTiXmi8C8FTp9beDtpvFYLaYVIrFTGpHSYFQkVM0XN1CN80A7V_jgOXKLjdCyhO_LHkVTCWRkOt9WQm1Tr7T_wv_Jp2gA</recordid><startdate>200410</startdate><enddate>200410</enddate><creator>Virmani, Ashraf</creator><creator>Binienda, Zbigniew</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200410</creationdate><title>Role of carnitine esters in brain neuropathology</title><author>Virmani, Ashraf ; Binienda, Zbigniew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c330t-eef523f2ea1771e94997213d13bf7875b63430190ba942fc9198cc858345b3db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Acetyl- l-carnitine</topic><topic>Brain</topic><topic>Brain - metabolism</topic><topic>Brain - pathology</topic><topic>Carnitine - chemistry</topic><topic>Carnitine - deficiency</topic><topic>Carnitine - metabolism</topic><topic>Carnitine - therapeutic use</topic><topic>Cell</topic><topic>Cell Membrane - metabolism</topic><topic>Cell Membrane - pathology</topic><topic>Clinical Trials as Topic</topic><topic>Esters - metabolism</topic><topic>FFA</topic><topic>Humans</topic><topic>l-Carnitine</topic><topic>Mitochondria</topic><topic>Neurons - metabolism</topic><topic>Neurons - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Virmani, Ashraf</creatorcontrib><creatorcontrib>Binienda, Zbigniew</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular Aspects of Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Virmani, Ashraf</au><au>Binienda, Zbigniew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of carnitine esters in brain neuropathology</atitle><jtitle>Molecular Aspects of Medicine</jtitle><addtitle>Mol Aspects Med</addtitle><date>2004-10</date><risdate>2004</risdate><volume>25</volume><issue>5</issue><spage>533</spage><epage>549</epage><pages>533-549</pages><issn>0098-2997</issn><eissn>1872-9452</eissn><abstract>l-Carnitine (L-C) is a naturally occurring quaternary ammonium compound endogenous in all mammalian species and is a vital cofactor for the mitochondrial oxidation of fatty acids. Fatty acids are utilized as an energy substrate in all tissues, and although glucose is the main energetic substrate in adult brain, fatty acids have also been shown to be utilized by brain as an energy substrate. L-C also participates in the control of the mitochondrial acyl-CoA/CoA ratio, peroxisomal oxidation of fatty acids, and the production of ketone bodies. Due to their intrinsic interaction with the bioenergetic processes, they play an important role in diseases associated with metabolic compromise, especially mitochondrial-related disorders. A deficiency of carnitine is known to have major deleterious effects on the CNS. Several syndromes of secondary carnitine deficiency have been described that may result from defects in intermediary metabolism and alterations principally involving mitochondrial oxidative pathways. Mitochondrial superoxide formation resulting from disturbed electron transfer within the respiratory chain may affect the activities of respiratory chain complexes I, II, III, IV, and V and underlie some CNS pathologies. This mitochondrial dysfunction may be ameliorated by L-C and its esters. In addition to its metabolic role, L-C and its esters such as acetyl- l-carnitine (ALC) posses unique neuroprotective, neuromodulatory, and neurotrophic properties which may play an important role in counteracting various disease processes. Neural dysfunction and metabolic imbalances underlie many diseases, and the inclusion of metabolic modifiers may provide an alternative and early intervention approach, which may limit further developmental damage, cognitive loss, and improve long-term therapeutic outcomes. The neurophysiological and neuroprotective actions of L-C and ALC on cellular processes in the central and peripheral nervous system show such effects. Indeed, many studies have shown improvement in processes, such as memory and learning, and are discussed in this review.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15363640</pmid><doi>10.1016/j.mam.2004.06.003</doi><tpages>17</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0098-2997
ispartof Molecular Aspects of Medicine, 2004-10, Vol.25 (5), p.533-549
issn 0098-2997
1872-9452
language eng
recordid cdi_proquest_miscellaneous_66872111
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acetyl- l-carnitine
Brain
Brain - metabolism
Brain - pathology
Carnitine - chemistry
Carnitine - deficiency
Carnitine - metabolism
Carnitine - therapeutic use
Cell
Cell Membrane - metabolism
Cell Membrane - pathology
Clinical Trials as Topic
Esters - metabolism
FFA
Humans
l-Carnitine
Mitochondria
Neurons - metabolism
Neurons - pathology
title Role of carnitine esters in brain neuropathology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T12%3A42%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20carnitine%20esters%20in%20brain%20neuropathology&rft.jtitle=Molecular%20Aspects%20of%20Medicine&rft.au=Virmani,%20Ashraf&rft.date=2004-10&rft.volume=25&rft.issue=5&rft.spage=533&rft.epage=549&rft.pages=533-549&rft.issn=0098-2997&rft.eissn=1872-9452&rft_id=info:doi/10.1016/j.mam.2004.06.003&rft_dat=%3Cproquest_cross%3E66872111%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66872111&rft_id=info:pmid/15363640&rft_els_id=S0098299704000482&rfr_iscdi=true